Use of crowdsourcing for cancer clinical trial development

Journal of the National Cancer Institute

Volumn 106, Issue 10, 2014, Pages

  Leiter, Amanda ^a   Sablinski, Tomasz ^b   Diefenbach, Michael ^a   Foster, Marc ^b   Greenberg, Alex ^b   Holland, John ^c   Oh, William K ^a   Galsky, Matthew D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Transparency Life Sciences   (United States)

^c Clinical Trials Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER RESEARCH; CLINICAL TRIAL (TOPIC); CONSENSUS; CROWDSOURCING; HUMAN; INTERNET; PRIORITY JOURNAL; PROGRAM FEASIBILITY; PROSTATE CANCER; SCIENTIST; SOCIAL NETWORK; STUDY DESIGN; SURVIVOR; FEASIBILITY STUDY; MALE; METHODOLOGY; NEOPLASM; PATIENT SELECTION; PROSTATE TUMOR;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; CROWDSOURCING; FEASIBILITY STUDIES; HUMANS; INTERNET; MALE; METFORMIN; NEOPLASMS; PATIENT SELECTION; PROSTATIC NEOPLASMS; RESEARCH DESIGN;

EID: 84908544554     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju258     Document Type: Article

References (6)

1. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. Jama. 2004;291(22):2720-2726.
2. Denicoff AM, McCaskill-Stevens W, Grubbs SS, et al. The national cancer institute-American society of clinical oncology cancer trial accrual symposium: summary and recommendations. J Oncol Pract. 2013;9(6):267-276.
3. Lara PN Jr., Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001;19(6):1728-1733.
4. George SL. Reducing patient eligibility criteria in cancer clinical trials. J Clin Oncol. 1996;14(4):1364-1370.
5. Surowiecki J. The Wisdom of Crowds. 1st ed. New York, NY: Anchor; 2005.
6. Cooper S, Khatib F, Treuille A, et al. Predicting protein structures with a multiplayer online game. Nature. 2010;466(7307):756-760.